Computing with bubbles, why hemorrhagic fever viruses are so bad, and how fat cells get fatter
**
Bubbles encode information
Electrons racing through circuits form the heart of today’s computers. Bubbles of gas could also serve as bits of information, performing all the basic steps needed for computation, according to a new paper in Science from MIT.
Manu Prakash and Neil Gershenfeld at MIT’s Center for Bits and Atoms created lab-on-a-chip systems where bubbles of nitrogen gas course through tiny water channels. Because the concentration of bubbles in a channel affects how quickly the fluid flows through it, the researchers were able to control how the bubbles moved through intersections of those channels. By precisely shaping those intersections, the researchers got them to perform like logic gates.
These gates sorted the bubbles, sending them down one path or another, depending on how the bubbles encountered each other at these crossroads. For example, if two bubbles met at an intersection designed to work as an “AND” logic gate, the bubbles joined together and traveled down one of two channels. The researchers were able to join these gates in more complex combinations, making a so-called ring oscillator, for example, that could keep time (see photo).

A bubble computer
(Credit: Felice Frankel and Manu Prakash, MIT)
Another local group, led by George Whitesides at Harvard, demonstrated, in the same issue of Science, a similar system to encode information using water droplets flowing through small channels of an oily liquid.
These liquid computers aren’t likely to replace our laptops, but they could be useful for programming lab-on-a-chip systems to do much more complex reactions, the researchers say. Mason Inman
Viruses sneak into cells on iron receptor
Hemorrhagic fever viruses cause gruesome and often fatal infections marked by uncontrolled bleeding throughout the body. While they are more commonly associated with Africa (Ebola being the most well known type), one family of the viruses pops up sporadically in South America, passing from rodents to humans to cause Bolivian, Argentine, Venezuelan, and Brazilian hemorrhagic fever.
In this week’s online edition of Nature, Hyeryun Choe and coworkers from Children’s Hospital and Harvard Medical School report that these viruses enter cells by hitching a ride on a protein, the transferrin receptor, that sits on the cell surface and transports iron into the cell. This route differs from that taken by the related Lassa virus from Africa, and opens up new opportunities for better treatment of infection.
The presence of the receptor in the lining of blood vessels could explain the bleeding and organ damage that comes with infection. And its abundance in activated immune cells could be one reason why the immune system is so helpless in fighting the infection.
An antibody specific for the transferrin receptor blocked viruses from entering cells, suggesting an immediate approach to treatment. Several transferrin receptor antibodies have been developed as possible anticancer agents and the investigators are planning to test these soon. Pat McCaffrey
Lean mice reveal new regulator of fat production
An enzyme that drives the early stages of fat cell maturation could provide a new target for antiobesity drugs.
The enzyme, xanthine oxidoreductase (XOR), is well known for its role in producing metabolic byproducts that cause the painful condition known as gout. Now, work from Jeffrey Flier and colleagues at the Beth Israel Deaconess Medical Center, with collaborators at Rockefeller University in New York, has uncovered an unsuspected role for XOR in the development of obesity.
The investigators showed that XOR activates a master gene regulator that signals cells to begin storing fat. Blocking the process could provide early intervention for obesity, stopping fat before it forms. The researchers found that obese mice had high levels of the enzyme, while mice lacking the protein had half the fat of their normal counterparts.
The byproducts of XOR not only cause gout but also contribute to the production of artery-clogging fats. The new work could explain why gout and heart disease often occur with obesity.
An XOR inhibitor commonly used to treat gout did not reduce fat cell maturation in cell culture. However, the investigators identified a different inhibitor that could. XOR inhibitors should be tested for their effects on body weight, they conclude.
The research appears in Cell Metabolism. Pat McCaffrey

Leave a Reply